FRMI INVESTOR NOTICE: Fermi Inc. Investors with Substantial Losses Have Opportunity to Lead the Fermi Class Action Lawsuit

San Diego, California–(Newsfile Corp. – January 11, 2026) – Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Fermi Inc. (NASDAQ: FRMI): (i) common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with Fermi’s October 2025 initial public offering (the “IPO”); and/or (ii) securities between October 1, […]

ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Bitdeer Technologies Group Investors to Secure Counsel Before Important Deadline in Securities Class Action – BTDR

NEW YORK CITY, NY / ACCESS Newswire / January 11, 2026 / WHY: New York, N.Y., January 11, 2026. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bitdeer Technologies Group (NASDAQ:BTDR) between June 6, 2024 and November 10, 2025, both dates inclusive (the "Class Period"), of the important February

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Firefly Aerospace

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Firefly Aerospace To Contact Him Directly To Discuss Their Options If you purchased or otherwise acquired: (a) Firefly common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company’s initial public offering conducted

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Blue Owl Capital Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OWL

NEW YORK, NY / ACCESS Newswire / January 11, 2026 / The Rosen Law Firm, P.A. WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Blue Owl Capital Inc. (NYSE:OWL) between February 6, 2025 and November 16, 2025, inclusive (the "Class Period"), of the important February 2, 2026 lead

SLM INVESTOR DEADLINE: SLM Corporation a/k/a Sallie Mae Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

San Diego, California–(Newsfile Corp. – January 11, 2026) – Robbins Geller Rudman & Dowd LLP announces that investors in SLM Corporation a/k/a Sallie Mae (NASDAQ: SLM) (NASDAQ: SLMBP) securities between July 25, 2025 and August 14, 2025, inclusive (the “Class Period”), have until February 17, 2026 to seek appointment as lead plaintiff of the SLM

Speediance Brings the Future of Smart Home Fitness to Life at CES 2026

Las Vegas, NV, Jan. 11, 2026 (GLOBE NEWSWIRE) — At CES 2026, Speediance introduced a fully immersive smart home gym experience that allowed attendees to step directly into the future of fitness. From January 6-9 at Booth #55339, visitors were invited not just to view technology, but to experience how intelligent training, wellness, and design

Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference

(NASDAQ:KRYS), Preliminary 4Q 2025 VYJUVEK net revenue of $106 million to $107 million Robust clinical pipeline with multibillion dollar opportunities and strong balance sheet for sustained growth PITTSBURGH, Jan. 11, 2026 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced selected preliminary unaudited 2025 financial results, including fourth quarter and full year

Speediance Brings the Future of Smart Home Fitness to Life at CES 2026

Speediance Brings the Future of Smart Home Fitness to Life at CES 2026 Immersive CES experience designed and executed by Cymatics Digital turns AI-powered training into a walk-in reality GlobeNewswire January 11, 2026 Las Vegas, NV, Jan. 11, 2026 (GLOBE NEWSWIRE) — At CES 2026, Speediance introduced a fully immersive smart home gym experience that

Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference

Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 11, 2026 Preliminary 4Q 2025 VYJUVEK net revenue of $106 million to $107 million Robust clinical pipeline with multibillion dollar opportunities and strong balance sheet for sustained growth PITTSBURGH, Jan. 11, 2026 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ:

Scroll to Top